MEDEOR THERAPEUTICS Trademark

Trademark Overview

On Wednesday, December 5, 2018, a trademark application was filed for MEDEOR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MEDEOR THERAPEUTICS trademark a serial number of 88217811. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 27, 2023. This trademark is owned by Medeor Therapeutics, Inc.. The MEDEOR THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for control and suppression of the immune system; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for induction of immune tolerance; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for treating and destroying cancer cells
medeor therapeutics

General Information

Serial Number88217811
Word MarkMEDEOR THERAPEUTICS
Filing DateWednesday, December 5, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBlood and bone marrow for medical purposes, namely, processed blood and bone marrow for preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for control and suppression of the immune system; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for induction of immune tolerance; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for treating and destroying cancer cells
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedeor Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94402

Trademark Events

Event DateEvent Description
Monday, November 27, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, November 27, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, November 27, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 10, 2023NON-FINAL ACTION E-MAILED
Thursday, August 10, 2023NON-FINAL ACTION WRITTEN
Saturday, June 17, 2023SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, December 5, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 10, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 5, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 5, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, March 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 4, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 26, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 26, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 2, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 1, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 1, 2019LETTER OF SUSPENSION E-MAILED
Tuesday, October 1, 2019SUSPENSION LETTER WRITTEN
Tuesday, September 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019NON-FINAL ACTION WRITTEN
Tuesday, March 5, 2019ASSIGNED TO EXAMINER
Saturday, December 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 8, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics medeor blood marrow bone processed namely purposes transplanted medical immune treating